Published On: January 13th, 2011
Dr. Alfred Mann, CEO of Mannkind Corp has developed an inhaled form of insulin, which the FDA is expected to decide on approval later this month. The product, called Afrezza, would be a major breakthrough in diabetes care as it would greatly reduce the need for needles.

See the original post:Â
Approval Expected for New Inhaled Form of Insulin/a>
Loading...
Leave a comment



Did you know:






